| Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto |
Globe Newswire |
10/21 |
07:00 |
| Kaltura to Announce Financial Results for Third Quarter 2026 on Monday, November 9, 2026 |
Globe Newswire |
10/21 |
07:00 |
| Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard |
Globe Newswire |
10/21 |
07:00 |
| Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026 |
Globe Newswire |
10/21 |
07:00 |
| Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness |
Globe Newswire |
10/21 |
07:00 |
| Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results |
Globe Newswire |
10/21 |
07:00 |
| Aya Gold & Silver Files Updated Preliminary Economic Assessment Technical Report for Boumadine Project |
Globe Newswire |
10/21 |
07:00 |
| Auddia Announces Completion of LT350 Phase 1 Feasibility Study and Advancement to Phase 2/3 Engineering with Fresh Consulting |
Globe Newswire |
10/21 |
07:00 |
| Elion Therapeutics to Present Turletricin Clinical Data at IDWeek 2026 |
Globe Newswire |
10/21 |
07:00 |
| Peptide Manufacturing Trends: How Oral Dosing Raises API Demand |
Globe Newswire |
10/21 |
07:00 |
| Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU) |
Globe Newswire |
10/21 |
07:00 |
| Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments |
Globe Newswire |
10/21 |
07:00 |
| Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met |
Globe Newswire |
10/21 |
07:00 |
| BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE |
Globe Newswire |
10/21 |
07:00 |
| PyroGenesis Announces Dubai Subsidiary to Address Growing Opportunities in Middle East and Asian Markets |
Globe Newswire |
10/21 |
07:00 |
| Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS) |
Globe Newswire |
10/21 |
07:00 |
| Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer |
Globe Newswire |
10/21 |
07:00 |
| Stifel Reports Third Quarter 2026 Results |
Globe Newswire |
10/21 |
07:00 |
| Old National Bancorp Reports Record Third Quarter 2026 Results |
Globe Newswire |
10/21 |
07:00 |
| REGO Guardian Gives Platforms Verified Parental Consent Through a Single API |
Globe Newswire |
10/21 |
06:59 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
10/21 |
06:55 |
| Injective Collaborates with BDACS to Bring Korea's First Won-Backed Stablecoin to Onchain RWAs |
Globe Newswire |
10/21 |
06:37 |
| AP Exclusive: Hungary’s Magyar vows accountability for Orbán era while holding firm on migration |
AP Online |
10/21 |
06:35 |
| U.S. Government Commits Nearly $250 Million to Port Mackenzie Rail Infrastructure, Supporting Alaska’s Resource development and providing a direct transport link to Nova Minerals planned critical minerals processing and refining hub. |
Globe Newswire |
10/21 |
06:30 |
| Korai Flix Inc. and APEX Tech Acquisition Inc. Agree to Merge and Create a Publicly Listed, Interactive Online Entertainment Platform |
Globe Newswire |
10/21 |
06:30 |
